Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01913938 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hemophagocytosis in Critically Ill Adult Patients

Study acronym: HCIAP
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 17, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 2020 to Jul 2025
    • Study completion date: Dec 2021 to Dec 2026
    v7
  2. Primary completion date: Jul 2018 to Jul 2020
    • Study completion date: Dec 2018 to Dec 2021
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Primary completion date: Jul 2017 to Jul 2018
    • Study completion date: Dec 2017 to Dec 2018
    v4
  5. Primary completion date: Jul 2015 to Jul 2017
    • Study completion date: Dec 2015 to Dec 2017
    • Publications: 5 to 6
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
Trial Details
NCT Number NCT01913938
Lead Sponsor University of Ulm
Conditions
(from sponsor)		 Hemophagocytosis
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov